Investigating the role of receptor interacting protein kinase 3 in venous thrombosis
Objective: Venous thromboembolism is a disease that encompasses both deep vein thrombosis and pulmonary embolism. Recent investigations have shown that receptor interacting protein kinase 3 (RIPK3), a protein known for its role in the programmed form of cell death necroptosis, may play a role in thr...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-01-01
|
| Series: | JVS - Vascular Science |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S266635032200075X |
| _version_ | 1797961076808089600 |
|---|---|
| author | Elise DeRoo, MD Mitri Khoury, MD Ting Zhou, PhD Huan Yang, PhD Amelia Stranz, BS, MS Catherine Luke, LVT, LAT Peter Henke, MD Bo Liu, PhD |
| author_facet | Elise DeRoo, MD Mitri Khoury, MD Ting Zhou, PhD Huan Yang, PhD Amelia Stranz, BS, MS Catherine Luke, LVT, LAT Peter Henke, MD Bo Liu, PhD |
| author_sort | Elise DeRoo, MD |
| collection | DOAJ |
| description | Objective: Venous thromboembolism is a disease that encompasses both deep vein thrombosis and pulmonary embolism. Recent investigations have shown that receptor interacting protein kinase 3 (RIPK3), a protein known for its role in the programmed form of cell death necroptosis, may play a role in thrombosis. Specifically, RIPK3 has been shown to promote platelet activation in arterial thrombosis and mixed lineage kinase domain-like pseudokinase (MLKL), a protein downstream of RIPK3 in the necroptosis pathway, has been shown to promote neutrophil extracellular trap formation in deep vein thrombosis. This investigation sought to comprehensively investigate the role of RIPK3 in deep vein thrombogenesis. Methods: The inferior vena cava ligation and stenosis models of deep vein thrombosis were used in C57BL/6J, RIPK3 wild-type (Ripk3+/+) and RIPK3-deficient (Ripk3–/–) mice. Downstream tissue analyses included measurement of thrombus weight and histological and Western blot analysis of tissues for markers of necroptosis and cell death. A subset of C57BL/6J mice were treated with a RIPK3 inhibitor to determine the effect on venous thrombosis. Results: C57BL/6J mice showed significant increases in thrombus weight from 6 to 48 hours. During the same time frame, RIPK3 progressively accumulated in the vein wall (a 35-fold increase from 0 to 48 hours). RIPK3 was present in the thrombus; however, it decreased with time. Although present in the thrombus, MLKL was nearly undetectable in the vein wall by Western blot at any timepoint. Immunostaining confirmed the high accumulation of RIPK3 in the vein wall, primarily colocalized to endothelial and smooth muscle cells. Phosphorylated MLKL, the active form of MLKL and executioner of necroptotic cell death, was detectable by immunostaining in the thrombus, but was present at low to undetectable levels in the vein wall. Propidium iodide and terminal deoxynucleotidyl transferase dUTP nick end labeling staining revealed a high burden of necrotic and apoptotic cells within the thrombus at 48 hours, but a relatively lower burden within the vein wall. Despite robust accumulation of RIPK3 within the vessel wall and the thrombus, knockout and inhibition of RIPK3 failed to impact thrombus incident or weight at 48 hours after inferior vena cava ligation. Neutrophil extracellular trap burden did not differ between Ripk3+/+ and Ripk3–/– mice. Conclusions: In mice, the vein wall responded to deep vein thrombosis induction with elevation of RIPK3 without showing markers of necroptosis and apoptosis. Studies using genetic or pharmacological inhibition of RIPK3 suggest that this cell death mediator may not have a major role in the acute phase of venous thrombogenesis. Further investigation is needed to determine if RIPK3 plays a potentially non-necroptotic role within the vein wall during later stages of thrombus resolution and vein wall remodeling. : Clinical relevance: Venous thromboembolism, encompassing deep vein thrombosis and pulmonary embolism is a major clinical problem, affecting approximately 1 million patients in the United States annually. Understanding the cellular and molecular mechanisms that drive deep vein thrombosis is critical to being able to develop future targeted therapies that not only prevent thrombus propagation, but also accelerate thrombus resolution and prevent adverse post-thrombotic vein wall remodeling without undue bleeding risks. Necroptosis, a form of programmed cell death, has been suggested to play a pathologic role in venous thrombus formation. This study investigates the role of the necroptotic protein receptor interacting protein kinase 3 in venous thrombosis. |
| first_indexed | 2024-04-11T00:53:44Z |
| format | Article |
| id | doaj.art-cb2147f040c44fa39c72501a6aa5eec5 |
| institution | Directory Open Access Journal |
| issn | 2666-3503 |
| language | English |
| last_indexed | 2024-04-11T00:53:44Z |
| publishDate | 2022-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | JVS - Vascular Science |
| spelling | doaj.art-cb2147f040c44fa39c72501a6aa5eec52023-01-05T06:48:07ZengElsevierJVS - Vascular Science2666-35032022-01-013365378Investigating the role of receptor interacting protein kinase 3 in venous thrombosisElise DeRoo, MD0Mitri Khoury, MD1Ting Zhou, PhD2Huan Yang, PhD3Amelia Stranz, BS, MS4Catherine Luke, LVT, LAT5Peter Henke, MD6Bo Liu, PhD7Department of Surgery, and Department of Cellular and Regenerative Biology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WIDepartment of Surgery, and Department of Cellular and Regenerative Biology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WIDepartment of Surgery, and Department of Cellular and Regenerative Biology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WIDepartment of Surgery, and Department of Cellular and Regenerative Biology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WIDepartment of Surgery, and Department of Cellular and Regenerative Biology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WIDepartment of Surgery, Division of Vascular Surgery, University of Michigan, Ann Arbor, MIDepartment of Surgery, Division of Vascular Surgery, University of Michigan, Ann Arbor, MIDepartment of Surgery, and Department of Cellular and Regenerative Biology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI; Correspondence: Bo Liu, PhD, University of Wisconsin-Madison, 1111 Highland Ave, WIMR 5137, Madison, WI 53705Objective: Venous thromboembolism is a disease that encompasses both deep vein thrombosis and pulmonary embolism. Recent investigations have shown that receptor interacting protein kinase 3 (RIPK3), a protein known for its role in the programmed form of cell death necroptosis, may play a role in thrombosis. Specifically, RIPK3 has been shown to promote platelet activation in arterial thrombosis and mixed lineage kinase domain-like pseudokinase (MLKL), a protein downstream of RIPK3 in the necroptosis pathway, has been shown to promote neutrophil extracellular trap formation in deep vein thrombosis. This investigation sought to comprehensively investigate the role of RIPK3 in deep vein thrombogenesis. Methods: The inferior vena cava ligation and stenosis models of deep vein thrombosis were used in C57BL/6J, RIPK3 wild-type (Ripk3+/+) and RIPK3-deficient (Ripk3–/–) mice. Downstream tissue analyses included measurement of thrombus weight and histological and Western blot analysis of tissues for markers of necroptosis and cell death. A subset of C57BL/6J mice were treated with a RIPK3 inhibitor to determine the effect on venous thrombosis. Results: C57BL/6J mice showed significant increases in thrombus weight from 6 to 48 hours. During the same time frame, RIPK3 progressively accumulated in the vein wall (a 35-fold increase from 0 to 48 hours). RIPK3 was present in the thrombus; however, it decreased with time. Although present in the thrombus, MLKL was nearly undetectable in the vein wall by Western blot at any timepoint. Immunostaining confirmed the high accumulation of RIPK3 in the vein wall, primarily colocalized to endothelial and smooth muscle cells. Phosphorylated MLKL, the active form of MLKL and executioner of necroptotic cell death, was detectable by immunostaining in the thrombus, but was present at low to undetectable levels in the vein wall. Propidium iodide and terminal deoxynucleotidyl transferase dUTP nick end labeling staining revealed a high burden of necrotic and apoptotic cells within the thrombus at 48 hours, but a relatively lower burden within the vein wall. Despite robust accumulation of RIPK3 within the vessel wall and the thrombus, knockout and inhibition of RIPK3 failed to impact thrombus incident or weight at 48 hours after inferior vena cava ligation. Neutrophil extracellular trap burden did not differ between Ripk3+/+ and Ripk3–/– mice. Conclusions: In mice, the vein wall responded to deep vein thrombosis induction with elevation of RIPK3 without showing markers of necroptosis and apoptosis. Studies using genetic or pharmacological inhibition of RIPK3 suggest that this cell death mediator may not have a major role in the acute phase of venous thrombogenesis. Further investigation is needed to determine if RIPK3 plays a potentially non-necroptotic role within the vein wall during later stages of thrombus resolution and vein wall remodeling. : Clinical relevance: Venous thromboembolism, encompassing deep vein thrombosis and pulmonary embolism is a major clinical problem, affecting approximately 1 million patients in the United States annually. Understanding the cellular and molecular mechanisms that drive deep vein thrombosis is critical to being able to develop future targeted therapies that not only prevent thrombus propagation, but also accelerate thrombus resolution and prevent adverse post-thrombotic vein wall remodeling without undue bleeding risks. Necroptosis, a form of programmed cell death, has been suggested to play a pathologic role in venous thrombus formation. This study investigates the role of the necroptotic protein receptor interacting protein kinase 3 in venous thrombosis.http://www.sciencedirect.com/science/article/pii/S266635032200075XVenous thrombosisMouse modelVein wallNecroptosisCell death |
| spellingShingle | Elise DeRoo, MD Mitri Khoury, MD Ting Zhou, PhD Huan Yang, PhD Amelia Stranz, BS, MS Catherine Luke, LVT, LAT Peter Henke, MD Bo Liu, PhD Investigating the role of receptor interacting protein kinase 3 in venous thrombosis JVS - Vascular Science Venous thrombosis Mouse model Vein wall Necroptosis Cell death |
| title | Investigating the role of receptor interacting protein kinase 3 in venous thrombosis |
| title_full | Investigating the role of receptor interacting protein kinase 3 in venous thrombosis |
| title_fullStr | Investigating the role of receptor interacting protein kinase 3 in venous thrombosis |
| title_full_unstemmed | Investigating the role of receptor interacting protein kinase 3 in venous thrombosis |
| title_short | Investigating the role of receptor interacting protein kinase 3 in venous thrombosis |
| title_sort | investigating the role of receptor interacting protein kinase 3 in venous thrombosis |
| topic | Venous thrombosis Mouse model Vein wall Necroptosis Cell death |
| url | http://www.sciencedirect.com/science/article/pii/S266635032200075X |
| work_keys_str_mv | AT elisederoomd investigatingtheroleofreceptorinteractingproteinkinase3invenousthrombosis AT mitrikhourymd investigatingtheroleofreceptorinteractingproteinkinase3invenousthrombosis AT tingzhouphd investigatingtheroleofreceptorinteractingproteinkinase3invenousthrombosis AT huanyangphd investigatingtheroleofreceptorinteractingproteinkinase3invenousthrombosis AT ameliastranzbsms investigatingtheroleofreceptorinteractingproteinkinase3invenousthrombosis AT catherinelukelvtlat investigatingtheroleofreceptorinteractingproteinkinase3invenousthrombosis AT peterhenkemd investigatingtheroleofreceptorinteractingproteinkinase3invenousthrombosis AT boliuphd investigatingtheroleofreceptorinteractingproteinkinase3invenousthrombosis |